You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

PEME+PEMB(MNT)

Cancer Type: Lung, Non-Small Cell      Intent: Palliative
Regimen Category: Evidence-informed
Drugs Used:
pembrolizumab (Compassionate),
Funding:
New Drug Funding Program
    Pemetrexed - Maintenance Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

You might also be interested in